Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
about
Main roads to melanomaMelanoma: from melanocyte to genetic alterations and clinical optionsLZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-cateninBrn-2 expression controls melanoma proliferation and is directly regulated by beta-cateninNr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesisTherapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?Targeting melanoma by small molecules: challenges aheadEmerging phytochemicals for prevention of melanoma invasionE-cadherin-catenin cell-cell adhesion complex and human cancerExpression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomasNuclear beta-catenin in basal cell carcinoma correlates with increased proliferationActivated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelRestoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiationIntegrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implicationsBeta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factorAssociation of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin proteinWNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistanceRad6 is a Potential Early Marker of Melanoma DevelopmentSpecific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeolThe Hedgehog signalling pathway and cancer.A possible role for the WNT-1 pathway in oral carcinogenesis.GSK3 takes centre stage more than 20 years after its discovery.Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway.A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?Use of gene expression and pathway signatures to characterize the complexity of human melanoma.Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma.CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.Neural cell adhesion molecule potentiates the growth of murine melanoma via β-catenin signaling by association with fibroblast growth factor receptor and glycogen synthase kinase-3β.Beta-catenin in the melanocyte lineage.Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinomaReduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype.β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomasBeta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression.Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferationThe transcription network regulating melanocyte development and melanoma.
P2860
Q21245465-D0D9320C-0E4A-4A37-96D8-76E6B07A216FQ21284811-AD042FD4-5263-4E5D-90DB-7F1CB703C322Q24300514-E20E23AF-0CFB-4C9F-8EAD-FA1E5BB12A2DQ24317170-13C8BF12-8277-4084-99B7-626C22D30DEEQ24673777-2157DFAA-49F8-404C-8193-24B9F35A3C10Q26782222-DDB2B2A8-8F39-47D7-B829-0F75C9E4828BQ26824642-8E4B550D-07F5-4995-9091-71F7C5568ADEQ27023283-58E6DA1A-16C3-4E46-A284-F60987341A18Q28142886-A07DA101-5608-43B2-9FEB-44B6B48CABACQ28268815-6617768E-6016-4F45-B9F4-7C52BC908718Q28273436-96EB4DA3-5107-4E02-8839-5F0C145BCBE0Q28306770-EBF34206-1CAD-42C2-A9A9-AC9BDA7C6B53Q28306934-32359920-3520-43ED-8D9A-76D4DFD12501Q28474843-EFD65B87-4DF6-450A-935E-DD4780A1264BQ28509336-CB86E444-2FEF-47E8-8F98-34E79D0D7357Q33263665-68A1F758-26CA-44E7-96BD-DA397C88093AQ33783736-D28565D6-D61D-4D84-852C-B6F017F34271Q33785885-D6EC2FF0-8828-40D6-BE3F-E04CC9BF55A9Q33988164-1096112E-7DE1-4CF0-8B14-593446FC62F4Q33999619-BD055E72-B1EE-4A6D-9D61-86CE2FF6D655Q34092180-1FE78DA7-1665-46D8-9F95-BC9BA34F55C4Q34180283-E2B356FD-2E47-47D3-AFEC-4CAFFD9A1E2FQ34199556-2168FCB1-F837-4008-A4B3-7878A9FD4A57Q34246978-91C4A685-516B-4F43-8F90-FDE59CFFB5C4Q34374129-27E865C0-DAA8-4F67-A73C-5E94A33D2706Q35006465-B045CCCF-1A35-4D7E-A4E0-938A15A17AF7Q35069175-9263F1EE-5D9F-4894-8755-1D7FA539A91FQ35071486-288D238D-1047-4930-9ABA-73C5797D15FDQ35081505-F305562B-9343-4EC0-AC0E-AB52A7D8BE6FQ35101747-9878B1AC-CFD8-4B36-B6D6-5BD3758AB065Q35110939-CEA0571E-6C68-4F17-AAA6-9318A7361410Q35129949-EF48EAF6-B344-4FDD-988C-CD0D7A3AAEB1Q35146535-9BF78B4F-7D0A-4103-B45D-AD7F0089A546Q35397312-FA7F200C-45FE-4AF3-9009-C6F990253FB4Q35550094-AEFA99EF-4271-409A-A281-AE03048A14C4Q35621787-ECC27523-3AFD-4CB3-AA30-C58CA306AAAAQ35679187-78909213-226C-4C52-86C5-C695CA0A7B6BQ35748395-D0463284-AC56-43F4-B49A-D0C56DE1CE4EQ35787861-12435E9E-DCD6-4AE1-BEF7-3B5C00A39A9EQ35834767-99DED7C7-5B80-4713-8941-B586FE82FD36
P2860
Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@ast
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@en
type
label
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@ast
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@en
prefLabel
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@ast
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@en
P2093
P2860
P1476
Frequent nuclear/cytoplasmic l ...... utations in malignant melanoma
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65278-9
P407
P577
1999-02-01T00:00:00Z